[1]
Aydin S. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides. 2015 Oct:72():4-15. doi: 10.1016/j.peptides.2015.04.012. Epub 2015 Apr 20
[PubMed PMID: 25908411]
[2]
Engvall E. The ELISA, enzyme-linked immunosorbent assay. Clinical chemistry. 2010 Feb:56(2):319-20. doi: 10.1373/clinchem.2009.127803. Epub 2009 Oct 22
[PubMed PMID: 19850633]
[3]
Shah K, Maghsoudlou P. Enzyme-linked immunosorbent assay (ELISA): the basics. British journal of hospital medicine (London, England : 2005). 2016 Jul:77(7):C98-101. doi: 10.12968/hmed.2016.77.7.C98. Epub
[PubMed PMID: 27388394]
[4]
Konstantinou GN. Enzyme-Linked Immunosorbent Assay (ELISA). Methods in molecular biology (Clifton, N.J.). 2017:1592():79-94. doi: 10.1007/978-1-4939-6925-8_7. Epub
[PubMed PMID: 28315213]
[5]
Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. The journals of gerontology. Series A, Biological sciences and medical sciences. 2008 Aug:63(8):879-84
[PubMed PMID: 18772478]
[6]
Gelkop S, Sobarzo A, Brangel P, Vincke C, Romão E, Fedida-Metula S, Strom N, Ataliba I, Mwiine FN, Ochwo S, Velazquez-Salinas L, McKendry RA, Muyldermans S, Lutwama JJ, Rieder E, Yavelsky V, Lobel L. The Development and Validation of a Novel Nanobody-Based Competitive ELISA for the Detection of Foot and Mouth Disease 3ABC Antibodies in Cattle. Frontiers in veterinary science. 2018:5():250. doi: 10.3389/fvets.2018.00250. Epub 2018 Oct 12
[PubMed PMID: 30370272]
Level 1 (high-level) evidence
[7]
de la Rica R, Stevens MM. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nature nanotechnology. 2012 Dec:7(12):821-4. doi: 10.1038/nnano.2012.186. Epub 2012 Oct 28
[PubMed PMID: 23103935]
[8]
Tabatabaei MS, Ahmed M. Enzyme-Linked Immunosorbent Assay (ELISA). Methods in molecular biology (Clifton, N.J.). 2022:2508():115-134. doi: 10.1007/978-1-0716-2376-3_10. Epub
[PubMed PMID: 35737237]
[9]
Lin AV. Direct ELISA. Methods in molecular biology (Clifton, N.J.). 2015:1318():61-7. doi: 10.1007/978-1-4939-2742-5_6. Epub
[PubMed PMID: 26160564]
[10]
Kohl TO, Ascoli CA. Direct Competitive Enzyme-Linked Immunosorbent Assay (ELISA). Cold Spring Harbor protocols. 2017 Jul 5:2017(7):pdb.prot093740. doi: 10.1101/pdb.prot093740. Epub 2017 Jul 5
[PubMed PMID: 28679705]
[11]
Hornbeck P. Enzyme-linked immunosorbent assays. Current protocols in immunology. 2001 May:Chapter 2():Unit 2.1. doi: 10.1002/0471142735.im0201s01. Epub
[PubMed PMID: 18432761]
[12]
Lin AV. Indirect ELISA. Methods in molecular biology (Clifton, N.J.). 2015:1318():51-9. doi: 10.1007/978-1-4939-2742-5_5. Epub
[PubMed PMID: 26160563]
[13]
Kohl TO, Ascoli CA. Indirect Immunometric ELISA. Cold Spring Harbor protocols. 2017 May 1:2017(5):. doi: 10.1101/pdb.prot093708. Epub 2017 May 1
[PubMed PMID: 28461658]
[14]
Kohl TO, Ascoli CA. Immunometric Double-Antibody Sandwich Enzyme-Linked Immunosorbent Assay. Cold Spring Harbor protocols. 2017 Jun 1:2017(6):pdb.prot093724. doi: 10.1101/pdb.prot093724. Epub 2017 Jun 1
[PubMed PMID: 28572188]
[15]
Lequin RM. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). Clinical chemistry. 2005 Dec:51(12):2415-8
[PubMed PMID: 16179424]
[16]
Tighe PJ, Ryder RR, Todd I, Fairclough LC. ELISA in the multiplex era: potentials and pitfalls. Proteomics. Clinical applications. 2015 Apr:9(3-4):406-22. doi: 10.1002/prca.201400130. Epub 2015 Mar 25
[PubMed PMID: 25644123]
[17]
Kuo HT, Yeh JZ, Wu PH, Jiang CM, Wu MC. Application of immunomagnetic particles to enzyme-linked immunosorbent assay (ELISA) for improvement of detection sensitivity of HCG. Journal of immunoassay & immunochemistry. 2012:33(4):377-87. doi: 10.1080/15321819.2012.655820. Epub
[PubMed PMID: 22963487]
[18]
Tiscione NB. The Validation of ELISA Screening According to SWGTOX Recommendations. Journal of analytical toxicology. 2018 Apr 1:42(3):e33-e34. doi: 10.1093/jat/bkx095. Epub
[PubMed PMID: 29300967]
[19]
Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2015 Jun 5:64(RR-03):1-137
[PubMed PMID: 26042815]
[20]
Sherwani S, Chowdhury M, Bugert JJ. ELISA for Molluscum Contagiosum Virus. Current protocols in microbiology. 2017 Nov 9:47():14A.6.1-14A.6.9. doi: 10.1002/cpmc.42. Epub 2017 Nov 9
[PubMed PMID: 29120484]
[21]
Atzori L, Deidda S, Aste N. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2008 Feb:143(1):1-8
[PubMed PMID: 18833046]
[22]
Weng X, Gaur G, Neethirajan S. Rapid Detection of Food Allergens by Microfluidics ELISA-Based Optical Sensor. Biosensors. 2016 Jun 7:6(2):24. doi: 10.3390/bios6020024. Epub 2016 Jun 7
[PubMed PMID: 27338488]
[23]
Kearney E. Internal quality control. Methods in molecular biology (Clifton, N.J.). 2013:1065():277-89. doi: 10.1007/978-1-62703-616-0_18. Epub
[PubMed PMID: 23996371]
Level 2 (mid-level) evidence
[24]
Kinns H, Pitkin S, Housley D, Freedman DB. Internal quality control: best practice. Journal of clinical pathology. 2013 Dec:66(12):1027-32. doi: 10.1136/jclinpath-2013-201661. Epub 2013 Sep 26
[PubMed PMID: 24072731]
Level 2 (mid-level) evidence
[25]
Westgard JO. Internal quality control: planning and implementation strategies. Annals of clinical biochemistry. 2003 Nov:40(Pt 6):593-611
[PubMed PMID: 14629798]
Level 2 (mid-level) evidence
[26]
Dubey A, Sonker A. Implementation of internal quality control program for monitoring of enzyme-linked immunosorbent assay performance at a blood center. Asian journal of transfusion science. 2021 Jan-Jun:15(1):21-29. doi: 10.4103/ajts.AJTS_59_19. Epub 2021 Jun 12
[PubMed PMID: 34349453]
Level 2 (mid-level) evidence
[27]
. Charting methods for internal quality control for competition ELISA. Methods in molecular biology (Clifton, N.J.). 2009:516():335-80. doi: 10.1007/978-1-60327-254-4_9. Epub
[PubMed PMID: 19219591]
Level 2 (mid-level) evidence
[28]
. Internal quality control and external quality management of data in practice. Methods in molecular biology (Clifton, N.J.). 2009:516():517-41. doi: 10.1007/978-1-60327-254-4_13. Epub
[PubMed PMID: 19219595]
Level 2 (mid-level) evidence
[29]
Lo J. Biological safety in the medical laboratory. Hong Kong medical journal = Xianggang yi xue za zhi. 2015 Jun:21(3):200. doi: 10.12809/hkmj154581. Epub
[PubMed PMID: 26045068]
[31]
Yücesan B, Özkan Ö. Laboratory Safety in Parasitology Laboratory. Turkiye parazitolojii dergisi. 2018 Jun:42(2):144-153. doi: 10.5152/tpd.2018.5598. Epub
[PubMed PMID: 30070646]
[32]
Rojo-Molinero E, Alados JC, de la Pedrosa EG, Leiva J, Pérez JL. [Safety in the Microbiology laboratory]. Enfermedades infecciosas y microbiologia clinica. 2015 Jun-Jul:33(6):404-10. doi: 10.1016/j.eimc.2014.06.014. Epub 2014 Nov 8
[PubMed PMID: 25444041]
[33]
Vonesch N, Tomao P, Di Renzi S, Vita S, Signorini S. [Biosafety in laboratories concerning exposure to biological agents]. Giornale italiano di medicina del lavoro ed ergonomia. 2006 Oct-Dec:28(4):444-56
[PubMed PMID: 17380946]
[34]
Mendicino D, Avalos C, Chiaraviglio R, Domínguez LB, Schaumburg F. Equipmentless point-of-care testing of dengue antibodies using ELISA and smartphones. Journal of pharmaceutical and biomedical analysis. 2025 Mar 15:255():116666. doi: 10.1016/j.jpba.2025.116666. Epub 2025 Jan 5
[PubMed PMID: 39787848]
[35]
Balogun OJ,Oladele RO,Ajibola OOE,Davies AA,Fashanu TA,Nwosu AO,Ekeng BE,Gangneux JP, Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria. Microbiology spectrum. 2025 Feb 6;
[PubMed PMID: 39912682]
[36]
Liang M, Hu X, Wang D, Tang X, Zhang Q, Li P. Catalytic boost in dual-active sites hierarchical hollow nanozymes: An enhanced robust and sensitive immunochromatographic assay for Aspergillus flavus. Biosensors & bioelectronics. 2025 Feb 5:():117223. doi: 10.1016/j.bios.2025.117223. Epub 2025 Feb 5
[PubMed PMID: 39924357]
[37]
Li W, Tian Z, Yu X, Xu H, Huang F, Yu J, Diao X. Quantification of serum daratumumab in multiple myeloma patients by LC-MS/MS, comparison with ELISA. Journal of pharmaceutical and biomedical analysis. 2025 Mar 15:255():116627. doi: 10.1016/j.jpba.2024.116627. Epub 2024 Dec 8
[PubMed PMID: 39671910]
[38]
Chávez-Valdés S, Marichal-Rodríguez AK, Chacón-Quintero Y, Martínez-Rosales R, Gómez-Hernández N, Ávila-Díaz L, Vázquez-Arteaga A, González-Formental H, Freyre-Corrales G, Coizeau-Rodríguez E, Guillen G, Lemos-Pérez G. Validation and clinical performance of a non-commercial ELISA for SARS-CoV-2 anti-RBD IgA antibodies. Analytical biochemistry. 2025 May:700():115787. doi: 10.1016/j.ab.2025.115787. Epub 2025 Jan 31
[PubMed PMID: 39894142]
Level 1 (high-level) evidence
[39]
Nandakumar V,Braun KMP,Willrich MAV, Challenges for complement functional assays in the clinical laboratory: From test validation to clinical interpretation. Journal of immunological methods. 2025 Feb 4;
[PubMed PMID: 39914516]
Level 1 (high-level) evidence
[40]
Behroozi Z, Hassani D, Mobini M, Bahadori T, Peyghami K, Judaki MA, Khoshnoodi J, Amiri MM, Golsaz-Shirazi F, Shokri F. Production and characterization of monoclonal antibodies against hepatitis B e-antigen and their potential application for development of HBeAg detection ELISA. Biologicals : journal of the International Association of Biological Standardization. 2025 Jan 31:90():101819. doi: 10.1016/j.biologicals.2025.101819. Epub 2025 Jan 31
[PubMed PMID: 39892062]